Pancreatitis associated with newer classes of antineoplastic therapiesGerald H. Clamon, Sarah L. Mott, Ravi B. Patel|The Journal of Community and Supportive Oncology|2017Cited by 9
RXDX-105 demonstrates anti-tumor efficacy in multiple preclinical cancer models driven by molecular alterations in RET or BRAF oncogenesLeona A. Martin, G.G. Li, Christine M. Walsh et al.|European Journal of Cancer|2016Cited by 0